Champlain Investment Partners, LLC Tandem Diabetes Care Inc Transaction History

Champlain Investment Partners, LLC

$13 Billion
Q1 2025

A detailed history of Champlain Investment Partners, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 1,368,888 shares of TNDM stock, worth $27.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,368,888

Previous 1,379,863 0.8%

Holding current value

$27.7 Million

Previous $49.7 Million 47.23%

% of portfolio

0.2%

Previous 0.33%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$17.89 - $37.53 $196,342 - $411,891	-10,975 Reduced 0.8%	1,368,888 $26.2 Million
Q4 2024 Feb 13, 2025	SELL	$27.34 - $41.78 $2.44 Million - $3.73 Million	-89,298 Reduced 6.08%	1,379,863 $49.7 Million
Q3 2024 Nov 12, 2024	SELL	$35.21 - $47.3 $5.65 Million - $7.59 Million	-160,366 Reduced 9.84%	1,469,161 $62.3 Million
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $3.53 Million - $6.2 Million	115,970 Added 7.66%	1,629,527 $65.7 Million
Q1 2024 May 13, 2024	SELL	$22.09 - $35.41 $359,514 - $576,297	-16,275 Reduced 1.06%	1,513,557 $53.6 Million
Q4 2023 Feb 13, 2024	SELL	$14.28 - $31.03 $1.23 Million - $2.67 Million	-86,047 Reduced 5.33%	1,529,832 $45.3 Million
Q3 2023 Nov 13, 2023	SELL	$19.33 - $36.22 $54,916 - $102,901	-2,841 Reduced 0.18%	1,615,879 $33.6 Million
Q2 2023 Aug 11, 2023	SELL	$24.18 - $42.46 $40 Million - $70.2 Million	-1,654,393 Reduced 50.54%	1,618,720 $39.7 Million
Q1 2023 May 12, 2023	BUY	$35.86 - $46.5 $7.32 Million - $9.5 Million	204,250 Added 6.66%	3,273,113 $133 Million
Q4 2022 Feb 13, 2023	SELL	$35.49 - $56.15 $1.96 Million - $3.09 Million	-55,110 Reduced 1.76%	3,068,863 $138 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $21.2 Million - $33.4 Million	484,310 Added 18.35%	3,123,973 $149 Million
Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $58.5 Million - $135 Million	1,098,338 Added 71.26%	2,639,663 $156 Million
Q1 2022 May 12, 2022	BUY	$101.89 - $150.09 $5.58 Million - $8.23 Million	54,812 Added 3.69%	1,541,325 $179 Million
Q4 2021 Feb 10, 2022	SELL	$118.18 - $153.21 $865,668 - $1.12 Million	-7,325 Reduced 0.49%	1,486,513 $224 Million
Q3 2021 Nov 12, 2021	SELL	$93.51 - $129.4 $4.93 Million - $6.82 Million	-52,732 Reduced 3.41%	1,493,838 $178 Million
Q2 2021 Aug 12, 2021	BUY	$77.0 - $100.19 $15.7 Million - $20.5 Million	204,410 Added 15.23%	1,546,570 $151 Million
Q1 2021 May 13, 2021	BUY	$81.28 - $104.34 $109 Million - $140 Million	1,342,160 New	1,342,160 $118 Million

Others Institutions Holding TNDM

# of Institutions

296

Shares Held

72.2M

Call Options Held

3.12M

Put Options Held

159K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.3B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account

Champlain Investment Partners, LLC Tandem Diabetes Care Inc Transaction History